R Shi, C Shan, X Duan, Z Chen, P Liu, J Song, T Song… - Nature, 2020 - nature.com
… , CR3022—a neutralizingantibody against SARS-CoV that was previously isolated from a patient convalescing from SARS—was found to be cross-reactive with the SARS-CoV-2 RBD. …
S Xiaojie, L Yu, Y Guang, Q Min - Stem cell research, 2021 - Elsevier
… In contrast to the antibodies from convalescent patient, in our lab, three potent SARS-CoV-2 neutralizingantibodies were screened from a combinatorial naïve library established 20 …
S Dispinseri, M Secchi, MF Pirillo, M Tolazzi… - Nature …, 2021 - nature.com
… SARS-CoV-2 neutralization assay and the LIPS assay for the detection of IgG, IgM, and IgA to SARS-CoV… coronaviruses, and to H1N1 influenza virus hemagglutinin. Our results indicate …
D Sterlin, A Mathian, M Miyara, A Mohr… - Science translational …, 2021 - science.org
… We confirmed that serum, BAL, and saliva antibodies have SARS-CoV-2 neutralization potential using a pseudoneutralization assay and validated with a viral neutralization assay. It …
… -SARSCoV-2 agents. However, the degree to which SARS-CoV-2 will adapt to evade neutralizing antibodies is … chimeric VSV/SARS-CoV-2 reporter virus, we show that functional SARS-…
J Seow, C Graham, B Merrick, S Acors, S Pickering… - Nature …, 2020 - nature.com
… of the neutralizingantibody response towards SARS-CoV-2 in some individuals. In contrast, individuals with high peak ID 50 for neutralization maintain neutralizingantibody titres in the …
… coronavirus. Here we report the isolation of sixty-one SARS-CoV-2-neutralizing monoclonal antibodies from five patients infected with SARS-CoV-2 and admitted to hospital with severe …
F Wu, A Wang, M Liu, Q Wang, J Chen, S Xia, Y Ling… - MedRxiv, 2020 - medrxiv.org
… , indicating that the antigenicity of SARS-CoV-2 is different from that of SARS-CoV. … that cross-neutralizingantibodies targeted the conserved epitopes of SARS-CoV and SARS-CoV-2 …
G Zhou, Q Zhao - International Journal of Biological Sciences, 2020 - ncbi.nlm.nih.gov
… neutralizingantibodies (NAbs) against SARS-CoV-2 will be greatly important therapeutic agents for the treatment of coronavirus … Herein, the host immune responses against SARS-CoV …